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Previously, split-thickness huntan skin grafted onto 
athyntic ntice has been shown to beconte ntarkedly 
hyperpigntented, but the factor(s) responsible for this 
hyperpigntentation had not been isolated. The 
present study describes the isolation and character-
ization of a potent ntelanogenic inhibitor front 
grafted huntan skin. Extracts frOnt grafted skin inhib-
ited, in a concentration-dependent ntanner, tyrosi-
nase activity of norntal hunt an ntelanocytes and of 
Cloudntan S91 nturine ntelanonta in culture. Sodiunt 
dodecylsulfate-polyacrylantide gel electrophoresis 
analysis of extracts frOnt pre- and post-grafted skin 
dentonstrated the presence of a protein doublet of 
approxintately 14 kD exclusively in the post-grafted 
skin. This protein inhibited both tyrosinase activity 
and cellular proliferation in a concentration-depen-
dent ntanner. The inhibition of tyrosinase activity in 
P revious studies from other institutions [1,2] and from this laboratory [3] have indicated that human skin xenografts on athymic mice undergo marked hyperpig-mentation. The pigmentation seems to be greater in meshes or split-thickness grafts than in full - thickness 
grafts [3] . At present, the exact molecular m echanism of this 
hyperpigmentation is not known. It was reported recently that the 
density and size of dihydroxyphenylalanine (DOPA)-positive mel a-
nocytes were significantly increased after grafting [3]. Concomitant 
with this increase, elevated levels of known m elanogenic enzynles 
and melanogenic peptides were also observed [4] . However, the 
mechanisms by which cellular proliferation and m elanogenic acti-
vation are stimulated are not known. 
To define the molecular mechanisms for this hyperpigmentation, 
we investigated the molecule(s) responsible for tllis phenomenon. 
First, the presence of a potent meianogellic inllibitor present 
exclusively in the grafted human skin was identified. Tllis illilibitor 
profoundly blocks both melanogenesis and cellular proliferation in 
culture. The present study describes the isolation, biochemical 
characterization, and biologic activity of tllis melanogenic illilibitor 
ill lIillO and ill I/ilro. 
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norntal huntan ntelanocytes was 53% at 0.5 ILg/ntl 
concentration, whereas this inhibition was alntost 
contplete in nturine ntelanonta cultures at 1.0 ILg/ntl. 
The protein did not inhibit either cellular prolifera-
tion or protein synthesis in norntal hunt an fibroblast 
cultures, and therefore ntay act specifically on ntela-
nocytes. Injections of the inhibitor corresponded 
with a delay and reduction in the quantity of pigntent 
in huntan skin 2 weeks after grafting. Multiple injec-
tions of the inhibitor into the hyperpigntented xe-
nografts (20 weeks after grafting) reversed the hyper-
pigntentation with no observable inflantntatory or 
toxic responses. The results indicate that hyperpig-
ntented hUntan skin xenografts contain a potent in-
hibitor of ntelanogenesis and ntelanocyte prolifera-
tion. Key words: atl,ymic mice.] Invest Derma.to1104:739-
743, 1995 
MATEIUALS AND METHODS 
Skin Grafting Procedures for grafting human skin onto athymic mice 
(nu/ nu, albino Balb/C) have been described previously [3] and were 
approved by the University of C incinnati Institutional Animal Care and Use 
Committee. Briefly, murine skin was excised. and split-thickness skin graft 
was sutured to wound punctures. At selected times after grafting (usually 
12-15 weeks), the grafted mice were sacrificed using an overdose of 
Nembutol and thc grafts were removed. 
Extraction of Proteins from Skin Both pre- and post-grafted skin was 
cut into small pieces after rcmoval of subcutaneous f.,t. Twenty percent 
(wt/vol) skin homogenates were prepared in phosphate-b~lffered saline 
containing 1 mM phenylmcthylsulfonyl fluorid e using a motorized homog-
eluzer (Polytron; Brinkman, Westbury, NY) . Mter ccntrifugation at 2000 
X g for 20 min, thc supematant was collected and centrifuged again at 
100,000 X g for 1 h to obtain clear soluble fraction. Both crude extract and 
supematant were filter sterili zed, and protein content was deternuned by 
the Bradford method [5]. 
Treatment of Cell Cultures with Skin Extract and Measurement of 
Tyrosinase Activity The culture conditions for nonnal human melano-
cytes [6] from neonatal foreskin and for Cloudman S91 m elanoma cells (7] 
were similar to those described previously. 
In a typical cell culture experiment, cells were inoculated at a density of 
1.5 X 105 cells iuto six-well plates containing the respective m edia for 
human melanocytes or C loudman S91 cells. Forty-eight hours later. media 
in all well s were replaced with fresh m edia contailung increasing concen-
trations of pre- or post-grafted skin supematant and/or electroelutcd 
proteins (mean = three per condition) . Between 48 and 72 h of the 
experiment, fresh media containing [' H]tyrosine (1 JJ.Ci/ml) plus supema-
tants or isolated proteins were added to the cultures. The conditioned 
m edium from each well was used to detemline the secreted tyrosine 
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hydro:\:ylase activIty of tyrosinase, according to a modification of the 
Pomerantz charcoal absorption method as described previously [8-10]. Cell 
counts per well were determined by Coulter counter. Triplicate wells were 
used for each experimental condition (mean = three per condition) . 
Responses of cell proliferation by human melanocytes or Cloudman S91 
cells were studied by measuring the rates of [3H]thymidine incorporation 
according to a previous study [7]. 
Sodium Dodecylsulfate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) and Electroelution of Proteins from Gel S!cin extracts (50 J.Lg 
protein) were subjected to SDS-PAGE using the discontinuous buffer system 
described by Laemmli [11] in 15% slab gel. After separation, the proteins 
were stained with a 0.05% wt/vol solution of Coomassie brilliant blue 
R-250. In some cases in which the separated proteins had to be electro-
eluted from the gels, only a part of the gel along with molecular-weight 
standards was cut out and stained. After destaining, both stained and 
unstained gels were aligned side by side, and the protein band of interest was 
excised from the unstained gel for electroelution. Proteins from the excised 
portions of the gel were eluted in buffer containing Tris (20 mM), glycine 
(150 mM), and SDS (0.05%). Electroelution was performed in an electro-
phoretic chamber (Schleicher & Schuell) at 150 V overnight. The fractions 
were collected, concentrated, aud dialyzed by Centricon-3 (Amicon Cor-
poration). The concentrated fractions were then filter sterilized, and protein 
contents were determined. 
If! Vivo Characterization of Electro eluted Proteins Proteins electro-
eluted from SDS gels were analyzed for their effects on hyperpigmented 
athymic mice (uu/nu) (20 weeks and 2 weeks after grafting). The animals 
were divided into two groups: the experimental group (A), with five mice, 
and the control group (B), including two mice. In group A, 50 /-tl containing 
approxinlately 2 ug of protein was injected subcutaneously into a circled 
area of the graft at weekly intervals. Five such injections were given on the 
left side of the grafted mice. As an internal control, 50 J.Ll of normal saline 
was injected on the right side of the same graft. In group B, no injection was 
given, and tlus condition provided baseline values for melanocyte counts. 
Biopsies were done in both groups at time 0 and 1 week after the final 
injection; specimens were processed for counting DOPA-positive melano-
cytes and for routine light microscopy to visualize any morphologic changes 
after the injections. Photographs were taken every week to assess any 
change of color in the skin graft. 
RESULTS 
Inhibition of Tyrosinase Activity in NorDlal HUDlan Mela-
nocytes Treated with Grafted Skin Extract Treatment of 
normal human melanocyte cultures with i.ncreasing concentrations 
of post-grafted skin extract (ranging' from 25 to 100 J-Lg/ml) 
resulted in an early increase in tyrosinase activity at lower concen-
trations of skin protein (25 J-Lg/ml), followed by a concentration-
dependent inhibition at higher concentrations. Compared with 
control, approximately 50% of tyrosinase activity was inhlbited at 
100 J-Lg/ml. Cells treated with pre-grafted skin extract showed no 
significant inhibition of tyrosinase activity (Fig 1). A similar pattern 
of inhibition was observed with murine melanoma S91 cells. 
Presence of 14-kD Protein in Post-Grafted HUDlan Skin 
Extracts and Supernatants To identify specific stimulatory or 
inhlbitory proteins associated with pre- and post-grafted skin, we 
performed SDS-PAGE analyses of crude extracts. As shown in Fig 
2, there was no major difference between pre-grafted crude extract 
and supernatant (lalle 1 IIersus lane 2) and between post-grafted skin 
extract and supernatant (Ialle 3 IIerS IlS lalle 4). However, compari-
sons of pre- and post-grafted skin showed differences in protein 
patterns. The protein in pre-grafted skin of approximately 50 kD 
and 66 kD probably represents albumin. Another significant differ-
ence was the presence of a doublet of approximately 14 kD present 
exclusively in the post-grafted skin (Ian.es 3, 4). A fraction extracted 
with Triton X-100 did not contain tlus protein, 311 indication that it 
is a soluble protein (laue 5). 
14-kD Protein frODl Post-Grafted Skin Inhibits Tyrosinase 
Activity in NOrDlal HUDlan Melanocytes Because the major 
difference between pre- and post-grafted skin was the presence of a 
14-kD b311d, we studied its effect on tyrosinase activity in normal 
human melanocytes. This protein was electroeluted from multiple 
gels and added to the cell cultures at concentrations of 0.25 J-Lg/ml 
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Figure 1. Inhibition of tyrosinase activity in normal human mela-
nocyte>s in the presence of extracts from post-grafted human skin. 
Cells were initially inoculated at 1.5 X 105 cells/well (ill six-well dishes) for 
48 h . 'J"hereafter, the medium was removed and fresh medium with various 
increasPlg concentrations of pre- and post-grafted s!cino extracts (ranging 
from 2S to 100 J.Lg/ml) was added. Two such treatments were given every 
48 h . Ouring the last treatlnent, the medium was supplemented with 1, 
3['H]cyrosinc (1 J.LCi/ml) . After 24 h, the medium was collt:cted for 
tyrosin~se assay and the cells were counted by Coulter Counter. The 
enzyme activity was calcu lated in Uluts of cpm/106 cells and expressed as a 
percenc of the control value. Values are the mean of three determinations :!: 
SD. 'p < 0.05 (Student t test) . 
and 0,50 J-Lg/ml. The supernatant from pre-grafted skin was run 
under identical conditions, and the gel corresponding to the 
position of 14-kD molecular-weight marker or 14-kD b311d was cut 
out ar:,.d the fraction was electroeluted to ensure that the observed 
effect was only due to the l4-kD band and was not from the 
polyaCrylamide gel buffer. As shown in Table I, the addition of 
variot:J.s concentrations of 14-kD protein frOI11 post-grafted skin 
resulte d in a concentration-dependent inlubition of tyrosinase 
activi0" Tlus inhibition was 53% at 0.5 J-Lg/ml con centration. No 
signibcant inhibition was observed when electroeluted fi.-action 
from vre-grafted skin was added to the cultures. 
14-kP Protein Inhibits Tyrosinase Activity and Cell Prolif-
eration in Murine Melanoma Cells The effect of 14-kD 
proteill isolated from post-grafted skin on melanogenesis in murine 
melaJ1-0ma cells was also determined. The cell cultures were treated 
with Jifferent concentratiollS of 14-kD protein ranging from 0.25 to 
1.0 ~g/ml. As shown in Fig 3, a concentration-dependent inhibi-
tion of tyrosinase activity was observed, 31ld the inhibition was 
almo9t complete (90%) at 1.0 J-Lg/ml concentration. A minimal 
inlubi.tion of tyrosi.nase activity was seen in the presence of the 
fraction electroeluted from the pre-grafted skin. Cell proliferation 
(eH]f;hyn1.i.dine incorpor~tion~ was also reduced significantly in the 
presePce of 14-kD protem (FIg 4). 
To examine whether the 14-kD protein isolated from post-
grafted skin was specific for m elanogenic enzyme and was not a 
gen eCal metabolic inlubitor, we studied its effect on cultured normal 
hum;V1 fibroblasts. Incubation of normal human fibroblasts with up 
to 10_fold lugher concentration of the protein (0.25 to 2.5 J-Lg/ml) 
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Figure 2. Presence of the 14-kD protein in post-grafted hU~an 
skin extracts and supernatants. SDS- PAGE analysis was done on pre-
and post-grafted human skin extracts and supernatants . Known conce~tra_ 
tions (50 J.Lg) of pre- and post-grafted skin extracts (2000 X g) and 
supernatants (100,000 X g) were subjected to SDS-PAGE (15% gel) I.\nder 
reducing conditions according to Laemmli's procednre (11) . The res~lved 
proteins were stained with Coomassie blue (R-250). Lalle 1, pre-gr<tfted 
crude skin extract; lalle 2, pre-grafted 100,000 X g skin supernatant; Illne 3 , 
post-grafted crude skin extract; lalle 4, post-grafted 100,000 X g sUP~rna­
tant; lalle 5, Triton X-l00 supernatant of post-grafted skin; lalle 6, low-
molecular-weight markers . An'olll/leads indicate migration of the l<\._kD 
doublet, present exclusively in grafted skin extract (/alle 3) and supern~tant 
(Ialle 4) . 
resulted in no inhibition of either [3H]thymidine or [ 3H]pr~line 
incorporation (data not shown). 
III Vivo Characterization of 14-kD Protein The injecti()n of 
14-kD band into 20 weeks post-grafted nude mice resulted in a 
marked reduction in the number of DOPA-positive melanocytes. 
The extent of reduction in melaJlOcytes ranged from 9% to 320;', 
(Table II). Parallel to tius decrease, skin color was also reduc~d at 
the site of inject ion. In contrast, no change in either DOPA-positive 
melanocytes or skin color was observed when the grafts ""ere 
injected with normal salille. Microscopic analysis of histologic 
changes after injection of protein and/or nOl:mal saline was per-
formed in a blinded mamler. Based on hematoA]'wl and ~osin 
Table I . 14-kD Protein from Grafted Human Skil\ 
Inhibits Tyrosinase Activity in Normal Human 
Melanocytes" 
Control 
Electroelution frOI11 donor skin 
0.25 /-Lg/ml 
0.50 J.Lg/ml 
Electroeluted protein from grafted 
skin 
0. 25 /-Lg/ml 
0. 50 /-Lg/ml 
" Data expressed as mean ± SD. 
Tyrosinase 
Activity 
(cpm/106 cells) 
248,209 ::!: 20,619 
217,698 ::!: 13,344 
214,315 ::!: 8,533 
156,909 ::!: 9,031 
116,677 ::!: 14,642 
Inhib:i.tion 
(% of 
Control) 
o 
12.3 ::t: 5.3 
13 .7 ::t: 3.4 
36.8 ::t: 3.6 
53 .0 ::t: 5.9 
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Figure 3. 14-kD protein from post-grafted skin inhibits tyrosinase 
activity in murine melanoma cells. Cells were inoculated at 0.2 X 106 
cells/ flask and were treated 48 h later with 0.25 to 1.0 /-Lg/ m1 of 14-kD 
protein electroeluted from the gel. For control, an equal volume corre-
spond.ing to 0.25 and 0.5 /-Lg protein was added. Diagollal-sllflded bars and 
opell IJal's represent the volume corresponding to 0.25 and 0.5 /-Lg/ml, 
respectively, of electro eluted protein from grafted human skin. The rest of 
the procedure was the same as described in the legend for Fig 1. Values are 
the mean of three detem1inations ::!: SD. • P < 0.05 (Student t test). Note 
a dose-dependent inhibition of tyrosinase activity in the presence of the 
lA-kD protein. 
stauUng patterns, no difference between experimental and control 
animals was observed . There was no injury pattern in eitiler the 
epidernus or dermis aJld no evidence of toxicity or inflammation. 
These results indicate that the electro eluted 14-kD protein when 
injected ;'1 lIillo selectively inlubits melanocyte proliferation without 
causing lustologic damage to epidennal cells. 
To confirm further the inlubitory effect of the 14-kD protein on 
melanocyte proliferation in lIivo , we studied human skin 2 weeks 
after grafting to atilynlic nUce. These skin samples also showed a 
sinUlar reduction in DOPA-positive melanocytes, which persisted 
throughout the experimental period . 
DISCUSSION 
The present study was performed to isolate and characterize the 
biologic factor(s) responsible for the observed hyperpigrnentation. 
The stimulation of tyrosinase and cellular proliferation in these 
melanocyte cultures in the presence of extracts was monitored to 
assess the presence of stimulatory factor. An initial stimulation of 
tyrosinase activity and cell proliferation at lower concentration 
suggests the presence of a stimulatory factor, whereas at lugher 
concentrations, inlubition of both tyrosinase activity and cellular 
proliferation indicates the presence of a melanogenic inhibitor in 
grafted skin. 
Comparison of the protein profiles between pre- and post-
grafted SkUl extracts revealed the presence of a doublet of approx-
imately 14 kD exclusively in post-grafted skin. This protein has a 
potent inlubitory effect on pigmentation. Although a protein of 
similar molecular weight was also found in normal skin from nude 
mice, that protein had no effect on melanogenesis. Initial biochem-
ical studies have indicated that the inlubitor is sensitive to protease 
treatment or ionic detergents, is thermolabile, and is completely 
inactivated at 100°C witlUn 5 nun. Tlus is the first report of tile 
presence of a potent melanogeluc inhibitor in grafted human skin. 
This molecule is wuque because it is a natural product of human 
skin . butial ill lIillo studies of the isolated protein on early (2 weeks) 
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Figure 4. 14-kD protein inhibits cellular proliferation of murine 
melanoma cells. The cultures of murine melanoma cells in 96-well plates 
(4000 cells/well) were treated with 0.25 and 0.5 JLg/ml of 14-kD protein 
electroeluted from post-grafted skin. For control, an equaJ volume corre-
sponding to 0.25 and 0.5 JLg protein was added. Diagollal-slrnded bars and 
opell bars represent the volume corresponding to 0.25 and 0.5 JLg/ml, 
respectively, of electrocluted protein from grafted human skin . Three such 
treatmcnts wcre given. Cell proliferation was measured in terms of[3H)thy-
midine incorporation into total cellular DNA, as described in Materials alld 
Methods. Values arc cl,e mean of three determinations :': SD. A concentra-
tion-dependent inhibition of ["H)thynudine incorporation was noticed III 
cultures treated with 14-kD protein. 
and late (20 w eek s) grafted athymic mice suggested that the protein 
has a signifi cant inhibitory effect, with no morphologic or anatomic 
changes to the grafted skin. 
A number of reports have described the presence of melanogenic 
inhibitors [1 2-15]. At present, none of these inhibitors have been 
isolated or characterized rigorously. Recent studies by Kameyama 
el al [16] indicated the presence of a potent melanogenic inhibitor 
in nonpig mented murine ]B/MS melanoma tumor cells. That 
inhibitor acts on tyrosinase to suppress melanin production dramat-
ica lly. The identity and nature of that inhibitor has not yet been 
comple te ly characterized. However, preli.minary data suggest that 
unlike the m elanogenic inhibitor reported he re , that inhibitor is not 
sensi tive to protease treatment or ionic d e tergents, but is inacti-
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vated by reducing agents. Recently, a post-tyrosinase inhibitor of 
melanogenesis, called blocking factor, has been described in S91 
melanoma cells [17,18]. T hat factor blocks the con version of 
5,6-dihydroxyindole to indole 5,6 quinone and is lost after treat-
ment of the cells with melanocyte-stimulating hormone. In another 
study, an inhibitor localize d in the melanin granule fraction of S91 
cells was described [19] . In addition, two large groups of melano-
genic inhibitors have been documented. The first group of inhibi-
tors did not affect isolated tyrosinase but was found to inhibit 
tyrosina.se synthesis and its glycosylation, thereby suppressing mel-
anogen esis in living cell systems [20]. The second group of 
inhibitors is effective in both isolated tyrosinase and li ving ceIl-
suppression systems [21] . Recently, Mishima [22] isolated low-, 
middle-, and high-molecular-weight inhibitors called 0' (A&B), {3, 
and y, with at A intrinsic inhibitor less than 6000 kD molecular 
w eig ht. T he at A intrinsic inhibitor was later identified as lactic 
acid [22]. Lactic acid markedly inhibits tyrosinase isoenzymes, 
particularly T 2 and Tl in B-16 cells, which suggests that it inhibits 
tyrosinase synthesis rather than directly suppressing the en zyme 
itself. 
The presence of melanization-inhibiting factor activity in the 
ventral skin of an amphibian XCI/OpUS lacl/is has been reported [23] . 
Subsequent studies demonstrated the presence of melanization-
inhibiting factor activity in other species of frogs and suggested that 
this factor might play an important role in dorsal-ventral pigment 
pattern formation [24,25] . Unlike the inhibitor described h ere, that 
inhibitor has a molecular w eig ht of approx im ately 450 kD. In 
addition to m elanization-inhibiting factor, Fukuzawa et al reported 
a higher-molecular-weight inhibito r of approximate ly 1500 kD 
from frog skin, which inhibits severely both neural crest cell 
outgrowth and melanoblast differentiation. i' 
T he identification of a melanogenic inhibitor in hyperpigmented 
skin grafts was unexpected. Rather, a potent m elanogenic stimu-
lator was antic ipated. We speculate that this inhjbitor may func tion 
as a feedback control in h eavily melanized skin and that the relative 
ratios of melanogenic stimulators to inhibitors detennines the 
ultimate m elanogenic olltcome: hyperp igmentation or h ypopig-
m entation. If this is the case, then this would explain why 
inflammation results in e ithe r post-inflammatory hyper- or hypo-
pigmentation. The m elanogenic inhibitor that we have isolated 
might eventually be usehll clinically for the treatment of variolls 
hyperpigmentary disorders. 
t Fukuzawa T, Samaraweera P, Law JI-I , Bagnara JT: Preliminary char-
acterization of an 3mplubian mclatuzation inlubiting factor (abstr). j>iglllCllt 
Cell Res 2:451, 1989. 
Table II. Multiple Injections of 14-kD Protein Inhibit DOPA-Positive Melanocytes in Grafted Nude Mice" 
Number of Injection of Electrociuted Protein Injection of Normal Saline 
DOPA-Positive 
Melanocytes Number of 'X) Reduction in Number of % Reduction in 
Group Before Injection Melanocytes Melanocytes Melanocytes Mclanocytes 
A (experimental) 
92B (full car) 635 :': 24 430 :': 31 32.3 :': 4.8 619 :': 6 2.5 :': 0.9 
92A (both cut lugh) 690 :': 19 490 :': 15 29 .0 :': 2.1 681 :': 5 1.3 :': 0.7 
92A (full ea r) 742 :': 30 559 :': 24 24 .6 :': 3.3 740 :': 13 0 
92A (right cut) 604 :': 30 550 :': 19 9.0 :': 3.1 600 :': 19 0 
92A (left cut) 625 :': 27 561 :': 25 10.1 :': 4.0 613 :': 7 2.0 :': 1.1 
B (control) 
92B (left cut) 586 :': 27 600 :': 21 0 600 :': 21 0 
92B (both cut low) 502 :': 23 523 :': 18 0 523 :': 18 0 
/I Animals in gro up A were injected subclitaneolisly w ith 50 , .. t.i containing 2 J.Lg of c1cctroclutcd proteins. Five slIch injections were given al weekly intervals 0 11 the left side of 
20 weeks grafted l11_i cc. Similarly, the injectio ns o f normal sa lin e were given 0 11 the ri ght side o rth e gl::tft in the saTlle Inice. Skin biopsies were t;lkcn before and after flT1al injectiolls. 
and DOPA-positive I11clallocytcs were coullted . In group 13 , 110 injections were given . Biopsies were taken before study and at 5 weeks to obt:lin baseline counts for DOPA-positive 
mclan ocytes. D~lta expressed as mean ± SD. 
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